Bioengineering (ISSN 2306-5354; CODEN: BIOEBG) is an international scientific open access journal on the science and technology of bioengineering published quarterly online by MDPI.
The Swiss Biotech Association represents the interests of the biotech sector, supports the entrepreneurship of biotech companies, and generates value for them through the following activities: Development of optimal framework conditions for the biotech sector to Representation of the biotech interests to policy makers, Support of Knowledge and technology transfer, Financing conditions for biotech companies, Education and professional development Networking of stakeholders at national and international level Through the development and maintenance of biotechnology-specific platforms Organisation and participation at national and international events Dissemination of accomplishments in biotechnology to the political audience and the general public, Through the national biotech platform and Increase of the visibility at national and international level Collaboration with strategic partners as a member of national and international umbrella organisations, through collaborations with life sciences clusters / initiatives and With national and European funding agencies is an organized and meaningful Biomaterials and Tissue Engineering communication resource for scientists, researchers, members of the business community, government, academia, and the general public.
BioNanoNet is an Austrian scientific network that specializes in Key Enabling Technologies (KETs) on national and international level, with a strong focus on bio- and nanotechnologies. BioNanoNet has the clear aim of supporting innovative interdisciplinary research by forming cooperative networks and synergistic collaborations, with special emphasis on (i) nanotoxicology, (ii) health, safety and nano-/medicine, and (iii) sensor technologies. The BioNanoNet Forschungsgesellschaft mbH is European key player in the field of nanosafety, specialised in developing nano-safety-by-design strategies together with researchers and industry, and coordinates the national technology platforms NanoMedicine-Austria and SusChem-AT. Additionally, the BioNanoNet GmbH supports national and international research projects in coordination, management, dissemination and communication.